{
    "clinical_study": {
        "@rank": "60532", 
        "acronym": "IEME", 
        "arm_group": [
            {
                "arm_group_label": "Extracorporeal morcellation", 
                "arm_group_type": "Experimental", 
                "description": "Extracorporeal morcellation in which patients are treated with \"protected\" removal by endobag and extracorporeal myoma morcellation with cold scissors and scalpel blade or with power morcellator used inside the bag itself"
            }, 
            {
                "arm_group_label": "Intracorporeal morcellation", 
                "arm_group_type": "Active Comparator", 
                "description": "Intracorporeal morcellation patients treated with standard intracorporeal morcellation, using reusable electronic device"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study protocol will be to compare the technique of intracorporeal\n      morcellation using reusable electronic device (standard technique) with a technique of\n      removal \"protected\" by endobag and extracorporeal myoma morcellation with cold scissors and\n      scalpel blade or with power morcellator used inside the bag itself."
        }, 
        "brief_title": "Intracorporeal Versus Extracorporeal Morcellation: Clinical Efficacy and Safety Outcomes", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Uterine Myoma", 
        "condition_browse": {
            "mesh_term": [
                "Myoma", 
                "Leiomyoma", 
                "Myofibroma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients undergoing laparoscopy for uterine myomas with international guidelines\n             surgical indications\n\n          -  Presence of at least one uterine myoma larger than 4 cm\n\n          -  Aged between 18 and 40 years\n\n        Exclusion Criteria:\n\n          -  Presence of uterine neoformations suspicious for malignancy\n\n          -  Medical major disorders associated\n\n          -  Acute or chronic psychiatric disorders\n\n          -  Ascertained Premenstrual syndrome\n\n          -  Use of drugs that can affect cognitive ability or state of consciousness and\n             alertness during the last six months prior to enrollment\n\n          -  Presence of calcified fibroids ultrasound examination\n\n          -  Presence of adnexal lesions\n\n          -  Detection of a pattern of endometrial hyperplasia with atypia determined in the\n             course endometrial biopsy performed for abnormal uterine bleeding\n\n          -  Abnormal PAP test\n\n          -  Positive Pregnancy Test\n\n          -  Previous use of laparoscopic surgery increased"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02086435", 
            "org_study_id": "SafeMorcellation"
        }, 
        "intervention": [
            {
                "arm_group_label": "Extracorporeal morcellation", 
                "description": "patients treated with \"protected\" removal by endobag and extracorporeal myoma morcellation with cold scissors and scalpel blade or with power morcellator used inside the bag itself", 
                "intervention_name": "Extracorporeal morcellation", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "protected morcellation", 
                    "morcellation in endobag"
                ]
            }, 
            {
                "arm_group_label": "Intracorporeal morcellation", 
                "description": "patients treated with standard intracorporeal morcellation, using reusable electronic device", 
                "intervention_name": "Intracorporeal morcellation", 
                "intervention_type": "Procedure", 
                "other_name": [
                    "Power morcellation", 
                    "Standard intracorporeal morcellation"
                ]
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Myomectomy", 
            "Laparoscopic myomectomy", 
            "Morcellation", 
            "Risk of dissemination", 
            "Uterine Sarcoma", 
            "Parasitic myoma"
        ], 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "email": "zullo@unicz.it", 
                "last_name": "Fulvio Zullo", 
                "phone": "39337947003"
            }, 
            "facility": {
                "address": {
                    "city": "Catanzaro", 
                    "country": "Italy", 
                    "state": "CZ", 
                    "zip": "88100"
                }, 
                "name": "Chair of Obstetrics and Gynecology - University division - UMG"
            }, 
            "investigator": {
                "last_name": "Roberta Venturella, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Controlled Trial on Intracorporeal Versus Extracorporeal Morcellation With Endobag Extraction in Patients Undergoing Laparoscopic Myomectomy: Clinical Efficacy and Safety Outcomes", 
        "overall_contact": {
            "email": "zullo@unicz.it", 
            "last_name": "Fulvio Zullo, MD, PHD", 
            "phone": "39337947003"
        }, 
        "overall_official": {
            "affiliation": "Magna Graecia University of Catanzaro", 
            "last_name": "Fulvio Zullo", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "calculated from the time, after secured hemostasis of the uterine breach, in which the myoma is clamped and subjected to intracorporeal or added in endobag for extracorporeal morcellation to the moment when the 'last fragment of myoma will be considered removed from the surgical field", 
            "measure": "Operative time", 
            "safety_issue": "Yes", 
            "time_frame": "The day of surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02086435"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Magna Graecia", 
            "investigator_full_name": "Fulvio Zullo", 
            "investigator_title": "Full Professor Obstetric Gynecology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "from skin incision to skin closure", 
                "measure": "Total operative time", 
                "safety_issue": "Yes", 
                "time_frame": "The day of surgery"
            }, 
            {
                "description": "expressed on the VAS scale where 1 means very bad handling and 10 excellent handling", 
                "measure": "Handling of morcellation", 
                "safety_issue": "No", 
                "time_frame": "The day of surgery"
            }, 
            {
                "description": "Blood loss will be calculated by the difference of Hb level 2 hours after surgery and the morning of the surgery", 
                "measure": "Blood loss", 
                "safety_issue": "Yes", 
                "time_frame": "2 hours after the end of surgery"
            }, 
            {
                "measure": "Postoperative hospital stay", 
                "safety_issue": "Yes", 
                "time_frame": "The day of patient discharge, average 4 day after surgery"
            }, 
            {
                "description": "measured on the VAS scale where 1 stands for a little pain and 10 for intense pain", 
                "measure": "Postoperative pain", 
                "safety_issue": "Yes", 
                "time_frame": "The day of patient discharge, average 4 day after surgery"
            }, 
            {
                "description": "need of transfusion or laparotomic conversion", 
                "measure": "Rate of complications", 
                "safety_issue": "Yes", 
                "time_frame": "The day of patient discharge, average 4 day after surgery"
            }
        ], 
        "source": "University Magna Graecia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Magna Graecia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}